SELLAS Life Sciences Group (SLS) Fair Value & DCF

SLS$7.86-0.17 -2.12%
BiotechnologyGrowth Stock
Compare
Market cap$1.60BEnterprise value$1.45BRevenue (TTM)$0Market position—

Score

71
Bullish
Value
59
Quality
53
Growth
100

SELLAS Life Sciences Group, Inc. (SLS) trades at $7.86 on $1.60B of equity value, with a trailing P/E of -39.56. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

SELLAS Life Sciences Group (SLS) Fair Value & DCF

SLS price $7.86 -0.17 -2.12%

Ticker
SLS
Price
$7.86
Change
-0.17 -2.12%
Market cap
$1.60B
Dividend yield
0.00%
Beta
2.70
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
71
Value
59
Quality
53
Growth
100

Stocklytics score rationale: value 59, quality 53, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener